Abiopharma

News list

WENTWORTH KORY JAMES 🔴 sold 1.7K shares of Entrada Therapeutics, Inc. (TRDA) at $5.43 Transaction Date: Sep 02, 2025 | Filing ID: 000003

Full text

News bot Sept. 4, 2025, 9:03 p.m.
🔍 WENTWORTH KORY JAMES (Executive)

Company: Entrada Therapeutics, Inc. (TRDA)

Report Date: 2025-09-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 1,734
Detailed Transactions and Holdings:
- Sold 1,734 shares of Common Stock at $5.4302 per share (Direct)
  Date: 2025-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 118,936.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of previously granted RSUs.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.36 to $5.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.